Sign in
4

Changes in Ownership

Tonix Pharmaceuticals Holding Corp. Filed Acc 0001615774-18-005289

Chief Financial Officer bought 300 shares at $4.10 ($1,230)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SAENGER BRADLEY Chief Financial Officer 2018-06-14 Purchase +300 $4.10 $1,230 3,079 D: show line 1 in the form
Open-market purchases · 300 sh · avg $4.10 · $1,230
Loading xslF345X03/s110839_form4.xml…